UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.06 +0.06 (+0.08%) GOLD FUTURES
2,313.40 +2.40 (+0.10%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,047.43 +991.04 (+2.15%)
Cyclacel Pharmaceuticals, Inc. (CYCCP)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | N/A |
| Enterprise value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.57 |
| 52-week change 3 | -58.89% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 22.20 |
| 52-week low 3 | 5.25 |
| 50-day moving average 3 | 16.88 |
| 200-day moving average 3 | 15.22 |
Share statistics
| Avg vol (3-month) 3 | 1.46k |
| Avg vol (10-day) 3 | 4.32k |
| Shares outstanding 5 | 12.5M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 1.14M |
| % held by insiders 1 | 0.48% |
| % held by institutions 1 | 0.06% |
| Shares short (15 Apr 2024) 4 | 56 |
| Short ratio (15 Apr 2024) 4 | 0.06 |
| Short % of float (15 Apr 2024) 4 | 0.02% |
| Short % of shares outstanding (15 Apr 2024) 4 | N/A |
| Shares short (prior month 15 Mar 2024) 4 | 56 |
Dividends & splits
| Forward annual dividend rate 4 | 0.6 |
| Forward annual dividend yield 4 | 8.16% |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 8.03 |
| Payout ratio 4 | N/A |
| Dividend date 3 | 01 Feb 2024 |
| Ex-dividend date 4 | 19 Jan 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -17,290.32% |
Management effectiveness
| Return on assets (ttm) | -86.33% |
| Return on equity (ttm) | -272.63% |
Income statement
| Revenue (ttm) | 420k |
| Revenue per share (ttm) | 0.49 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -25.42M |
| Net income avi to common (ttm) | -22.76M |
| Diluted EPS (ttm) | -2.05 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 3.38M |
| Total cash per share (mrq) | 2.56 |
| Total debt (mrq) | 37k |
| Total debt/equity (mrq) | 6.10% |
| Current ratio (mrq) | 0.91 |
| Book value per share (mrq) | 0.57 |
Cash flow statement
| Operating cash flow (ttm) | -16.11M |
| Levered free cash flow (ttm) | -11.76M |
© 2024 Yahoo. All rights reserved.